Annotation (Toggle Detail/Summary View) Gene-Chemical Interaction AnnotationsTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | decreases expression | EXP | | 6480464 | epigallocatechin gallate results in decreased expression of FASN mRNA | CTD | PMID:16988119 | (-)-epigallocatechin 3-gallate | decreases expression | ISO | RGD:1347691 | 6480464 | epigallocatechin gallate results in decreased expression of FASN mRNA | CTD | PMID:20816778 | (R)-mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [atorvastatin results in increased expression of FASN mRNA] | CTD | PMID:12056585 | (S)-nicotine | multiple interactions | ISO | | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [Nicotine results in decreased activity of FASN protein]; more ... | CTD | PMID:17635921 | (S)-nicotine | decreases activity | ISO | | 6480464 | Nicotine results in decreased activity of FASN protein | CTD | PMID:17635921 | 17alpha-ethynylestradiol | multiple interactions | ISO | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of FASN mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of FASN mRNA | CTD | PMID:17108234 PMID:15953391 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of FASN mRNA | CTD | PMID:16174780 | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of FASN mRNA | CTD | PMID:15953391 PMID:17108234 | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of FASN mRNA | CTD | PMID:16079270 | 17beta-estradiol | decreases expression | ISO | RGD:1347691 | 6480464 | Estradiol results in decreased expression of FASN mRNA | CTD | PMID:20106945 | 17beta-estradiol | increases expression | ISO | RGD:1347691 | 6480464 | Estradiol results in increased expression of FASN mRNA | CTD | PMID:23019147 | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | ISO | RGD:1347691 | 6480464 | Metribolone results in increased expression of FASN protein | CTD | PMID:17152098 | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | ISO | RGD:1347691 | 6480464 | Metribolone promotes the reaction [NDRG1 protein binds to FASN protein] | CTD | PMID:17220478 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | | 6480464 | Dihydrotestosterone results in increased expression of FASN mRNA | CTD | PMID:16990341 | 2,2',4,4',5,5'-hexachlorobiphenyl | decreases expression | ISO | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of FASN mRNA | CTD | PMID:20005886 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA]; more ... | CTD | PMID:21851831 | 2,2',4,4',5,5'-hexachlorobiphenyl | decreases expression | ISO | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of FASN mRNA | CTD | PMID:20005886 PMID:21851831 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of FASN mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | CTD | PMID:15800033 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | CTD | PMID:15800033 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | CTD | PMID:16054898 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | CTD | PMID:16054898 more ... | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASN mRNA | CTD | PMID:21846477 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | CTD | PMID:15800033 more ... | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA]; more ... | CTD | PMID:21851831 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | CTD | PMID:15800033 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | CTD | PMID:16960034 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | CTD | PMID:15800033 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | CTD | PMID:15800033 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | CTD | PMID:16054898 PMID:16960034 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | CTD | PMID:18295293 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | CTD | PMID:16960034 PMID:16054898 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASN protein | CTD | PMID:16548065 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | CTD | PMID:20005886 more ... | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of FASN mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of FASN mRNA | CTD | PMID:21346803 | 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:1347691 | 6480464 | Glucosamine results in increased expression of FASN mRNA | CTD | PMID:22096489 | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of FASN mRNA | CTD | PMID:19692669 | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of FASN mRNA | CTD | PMID:19692669 PMID:20959002 | 3,3',5-triiodo-L-thyronine | increases expression | EXP | | 6480464 | Triiodothyronine results in increased expression of FASN mRNA | CTD | PMID:15953391 | 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in increased expression of FASN mRNA | CTD | PMID:19162173 | 3H-1,2-dithiole-3-thione | decreases expression | ISO | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of FASN mRNA | CTD | PMID:15302862 | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of FASN protein | CTD | PMID:18413838 | 4-coumaric acid | decreases expression | ISO | | 6480464 | 4-coumaric acid results in decreased expression of FASN mRNA | CTD | PMID:21870829 | 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | ISO | | 6480464 | [AICA ribonucleotide results in increased activity of PRKAA2 protein] which results in decreased activity of FASN protein | CTD | PMID:17635921 | 7,12-dimethyltetraphene | multiple interactions | EXP | | 6480464 | [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of FASN protein | CTD | PMID:22248470 | 7,12-dimethyltetraphene | increases expression | EXP | | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FASN protein | CTD | PMID:22248470 | 8'-apo-beta,psi-caroten-8'-al | decreases expression | ISO | RGD:1347691 | 6480464 | apocarotenal results in decreased expression of FASN mRNA | CTD | PMID:17034753 | 9-cis-retinoic acid | decreases expression | ISO | RGD:1347691 | 6480464 | alitretinoin results in decreased expression of FASN mRNA | CTD | PMID:15982314 | acarbose | decreases expression | EXP | | 6480464 | Acarbose results in decreased expression of FASN mRNA; more ... | CTD | PMID:8101498 | aldehydo-D-glucosamine | increases expression | ISO | RGD:1347691 | 6480464 | Glucosamine results in increased expression of FASN mRNA | CTD | PMID:22096489 | all-trans-retinoic acid | increases expression | ISO | RGD:1347691 | 6480464 | Tretinoin metabolite results in increased expression of FASN mRNA | CTD | PMID:15982314 | all-trans-retinoic acid | decreases expression | ISO | RGD:1347691 | 6480464 | Tretinoin results in decreased expression of FASN mRNA | CTD | PMID:15982314 | alpha-linolenic acid | decreases expression | EXP | | 6480464 | alpha-Linolenic Acid results in decreased expression of FASN mRNA | CTD | PMID:14563831 | arachidonic acid | decreases expression | ISO | | 6480464 | Arachidonic Acid results in decreased expression of FASN mRNA | CTD | PMID:19159447 | benzene | decreases expression | EXP | | 6480464 | Benzene results in decreased expression of FASN mRNA | CTD | PMID:15878777 | benzo[a]pyrene | decreases expression | ISO | | 6480464 | Benzo(a)pyrene results in decreased expression of FASN mRNA | CTD | PMID:19770486 | benzo[a]pyrene | increases expression | ISO | | 6480464 | Benzo(a)pyrene results in increased expression of FASN mRNA | CTD | PMID:21569818 PMID:21964900 | benzo[a]pyrene | multiple interactions | ISO | RGD:1347691 | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FASN mRNA; more ... | CTD | PMID:17690111 | benzo[a]pyrene | decreases expression | ISO | RGD:1347691 | 6480464 | Benzo(a)pyrene results in decreased expression of FASN mRNA | CTD | PMID:16269432 | benzo[a]pyrene | multiple interactions | ISO | | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of FASN mRNA] | CTD | PMID:22228805 | benzo[a]pyrene | increases expression | ISO | | 6480464 | Benzo(a)pyrene results in increased expression of FASN mRNA | CTD | PMID:21569818 | benzo[b]fluoranthene | multiple interactions | ISO | RGD:1347691 | 6480464 | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FASN mRNA | CTD | PMID:17690111 | beta-D-glucosamine | increases expression | ISO | RGD:1347691 | 6480464 | Glucosamine results in increased expression of FASN mRNA | CTD | PMID:22096489 | bezafibrate | increases expression | ISO | | 6480464 | Bezafibrate results in increased expression of FASN mRNA | CTD | PMID:17118139 | bezafibrate | affects expression | EXP | | 6480464 | Bezafibrate affects the expression of FASN mRNA | CTD | PMID:17719200 | bezafibrate | increases expression | ISO | | 6480464 | Bezafibrate results in increased expression of FASN protein | CTD | PMID:19124612 | bezafibrate | increases expression | ISO | | 6480464 | Bezafibrate results in increased expression of FASN mRNA | CTD | PMID:17118139 PMID:19124612 | bezafibrate | decreases expression | ISO | | 6480464 | Bezafibrate results in decreased expression of FASN protein; more ... | CTD | PMID:19124612 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | | 6480464 | Diethylhexyl Phthalate results in decreased expression of FASN mRNA | CTD | PMID:19245819 | bisphenol A | increases expression | ISO | | 6480464 | bisphenol A results in increased expression of FASN mRNA; more ... | CTD | PMID:21932408 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FASN mRNA | CTD | PMID:20019905 | buta-1,3-diene | decreases expression | ISO | | 6480464 | 1,3-butadiene results in decreased expression of FASN mRNA | CTD | PMID:21147608 | calcitriol | multiple interactions | ISO | RGD:1347691 | 6480464 | Cycloheximide inhibits the reaction [Calcitriol results in decreased expression of FASN mRNA] | CTD | PMID:12798352 | calcitriol | decreases expression | ISO | RGD:1347691 | 6480464 | Calcitriol results in decreased expression of FASN mRNA | CTD | PMID:12798352 | carvedilol | multiple interactions | EXP | | 6480464 | carvedilol inhibits the reaction [Ethanol results in increased expression of FASN mRNA] | CTD | PMID:22413959 | celecoxib | decreases activity | ISO | | 6480464 | celecoxib results in decreased activity of FASN protein | CTD | PMID:19159447 | celecoxib | multiple interactions | ISO | | 6480464 | Dinoprostone promotes the reaction [celecoxib results in decreased activity of FASN protein] | CTD | PMID:19159447 | cerulenin | multiple interactions | ISO | RGD:1347691 | 6480464 | [Cerulenin results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine | CTD | PMID:18723500 | cerulenin | decreases expression | ISO | | 6480464 | Cerulenin results in decreased expression of FASN mRNA | CTD | PMID:15707987 | cerulenin | decreases activity | ISO | | 6480464 | Cerulenin results in decreased activity of FASN protein | CTD | PMID:15707987 | cerulenin | decreases activity | ISO | RGD:1347691 | 6480464 | Cerulenin results in decreased activity of FASN protein | CTD | PMID:12798352 | chlorogenic acid | decreases expression | ISO | | 6480464 | Chlorogenic Acid results in decreased expression of FASN mRNA | CTD | PMID:21870829 | choline | multiple interactions | ISO | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FASN gene | CTD | PMID:20938992 | choline | multiple interactions | ISO | | 6480464 | [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of FASN mRNA | CTD | PMID:23038002 | ciguatoxin CTX1B | affects expression | ISO | | 6480464 | Ciguatoxins affects the expression of FASN mRNA | CTD | PMID:18353800 | cis-caffeic acid | decreases expression | ISO | | 6480464 | caffeic acid results in decreased expression of FASN mRNA | CTD | PMID:21870829 | cisplatin | multiple interactions | ISO | RGD:1347691 | 6480464 | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein] which results in increased susceptibility to Cisplatin; more ... | CTD | PMID:21442130 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of FASN protein | CTD | PMID:22023808 | clofibrate | decreases expression | ISO | | 6480464 | Clofibrate results in decreased expression of FASN mRNA | CTD | PMID:17585979 | clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of FASN protein | CTD | PMID:8240402 | clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of FASN protein | CTD | PMID:6821269 | clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of FASN mRNA | CTD | PMID:19224547 PMID:17522070 | clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of FASN mRNA | CTD | PMID:17522070 PMID:19224547 | clozapine | increases expression | ISO | RGD:1347691 | 6480464 | Clozapine results in increased expression of FASN mRNA | CTD | PMID:16027736 PMID:17052361 | clozapine | increases expression | ISO | RGD:1347691 | 6480464 | Clozapine results in increased expression of FASN mRNA | CTD | PMID:17052361 PMID:16027736 | cobalt dichloride | decreases expression | ISO | RGD:1347691 | 6480464 | cobaltous chloride results in decreased expression of FASN mRNA | CTD | PMID:19320972 | copper atom | multiple interactions | ISO | RGD:1347691 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of FASN mRNA | CTD | PMID:20971185 | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of FASN mRNA | CTD | PMID:11110846 | copper atom | decreases expression | ISO | | 6480464 | Copper results in decreased expression of FASN mRNA | CTD | PMID:17205981 | copper atom | multiple interactions | ISO | RGD:1347691 | 6480464 | [Thiosemicarbazones binds to Copper] which results in increased expression of FASN protein | CTD | PMID:20931265 | copper atom | multiple interactions | EXP | | 6480464 | [Copper deficiency co-treated with Fructose] results in increased expression of FASN protein | CTD | PMID:21781943 | copper(0) | multiple interactions | ISO | RGD:1347691 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of FASN mRNA | CTD | PMID:20971185 | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of FASN mRNA | CTD | PMID:11110846 | copper(0) | decreases expression | ISO | | 6480464 | Copper results in decreased expression of FASN mRNA | CTD | PMID:17205981 | copper(0) | multiple interactions | ISO | RGD:1347691 | 6480464 | [Thiosemicarbazones binds to Copper] which results in increased expression of FASN protein | CTD | PMID:20931265 | copper(0) | multiple interactions | EXP | | 6480464 | [Copper deficiency co-treated with Fructose] results in increased expression of FASN protein | CTD | PMID:21781943 | copper(2+) sulfate | decreases expression | ISO | RGD:1347691 | 6480464 | Copper Sulfate results in decreased expression of FASN mRNA | CTD | PMID:19549813 | corticosterone | multiple interactions | EXP | | 6480464 | [Corticosterone co-treated with oleoyl-estrone] affects the expression of FASN mRNA | CTD | PMID:19545626 | coumarin | affects expression | EXP | | 6480464 | coumarin affects the expression of FASN mRNA | CTD | PMID:16963487 | cycloheximide | multiple interactions | ISO | RGD:1347691 | 6480464 | Cycloheximide inhibits the reaction [Calcitriol results in decreased expression of FASN mRNA] | CTD | PMID:12798352 | cyclosporin A | decreases expression | ISO | RGD:1347691 | 6480464 | Cyclosporine results in decreased expression of FASN mRNA | CTD | PMID:20106945 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of FASN mRNA | CTD | PMID:19224547 | D-glucose | increases expression | ISO | | 6480464 | Glucose results in increased expression of FASN mRNA | CTD | PMID:15066988 | D-glucose | multiple interactions | ISO | RGD:1347691 | 6480464 | [Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides; more ... | CTD | PMID:18482975 | D-glucose | increases expression | ISO | RGD:1347691 | 6480464 | Glucose results in increased expression of FASN protein | CTD | PMID:18482975 | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of FASN mRNA | CTD | PMID:17522070 | dexamethasone | increases expression | ISO | | 6480464 | Dexamethasone results in increased expression of FASN mRNA | CTD | PMID:22956630 | dexamethasone | multiple interactions | ISO | | 6480464 | butylparaben promotes the reaction [Dexamethasone results in increased expression of FASN mRNA] | CTD | PMID:22956630 | dibenz[a,h]anthracene | multiple interactions | ISO | RGD:1347691 | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FASN mRNA | CTD | PMID:17690111 | dibenzo[a,l]pyrene | decreases expression | ISO | RGD:1347691 | 6480464 | dibenzo(a,l)pyrene results in decreased expression of FASN mRNA | CTD | PMID:16269432 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of FASN mRNA | CTD | PMID:21266533 | diclofenac | decreases expression | EXP | | 6480464 | Diclofenac results in decreased expression of FASN mRNA | CTD | PMID:19022234 | diethyl maleate | decreases expression | EXP | | 6480464 | diethyl maleate results in decreased expression of FASN mRNA | CTD | PMID:21161181 | doxorubicin | increases expression | ISO | RGD:1347691 | 6480464 | Doxorubicin results in increased expression of FASN mRNA | CTD | PMID:17089011 | doxorubicin | decreases response to substance | ISO | RGD:1347691 | 6480464 | FASN protein results in decreased susceptibility to Doxorubicin | CTD | PMID:18281512 | doxorubicin | multiple interactions | ISO | RGD:1347691 | 6480464 | FASN protein inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:18281512 | elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of FASN mRNA | CTD | PMID:19022953 | elemental selenium | increases expression | ISO | RGD:1347691 | 6480464 | Selenium results in increased expression of FASN mRNA | CTD | PMID:19244175 | erythromycin estolate | decreases expression | EXP | | 6480464 | Erythromycin Estolate results in decreased expression of FASN mRNA | CTD | PMID:17522070 | ethanol | multiple interactions | ISO | | 6480464 | Ethanol inhibits the reaction [Fish Oils results in decreased expression of FASN mRNA]; more ... | CTD | PMID:18620774 | ethanol | increases expression | ISO | | 6480464 | Ethanol results in increased expression of FASN mRNA | CTD | PMID:18620774 more ... | ethanol | multiple interactions | ISO | | 6480464 | resveratrol inhibits the reaction [Ethanol results in increased expression of FASN mRNA] | CTD | PMID:18755807 | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of FASN mRNA | CTD | PMID:22413959 | ethanol | multiple interactions | EXP | | 6480464 | carvedilol inhibits the reaction [Ethanol results in increased expression of FASN mRNA] | CTD | PMID:22413959 | ethanol | increases expression | ISO | | 6480464 | Ethanol results in increased expression of FASN mRNA | CTD | PMID:18620774 PMID:20637825 | ethanol | multiple interactions | ISO | | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of FASN mRNA] | CTD | PMID:22173916 | ethanol | decreases expression | ISO | | 6480464 | Ethanol results in decreased expression of FASN mRNA | CTD | PMID:22173916 | ethanol | multiple interactions | EXP | | 6480464 | [Fish Oils co-treated with Ethanol] results in increased expression of FASN mRNA | CTD | PMID:17347304 | ethanol | increases expression | ISO | | 6480464 | Ethanol results in increased expression of FASN mRNA | CTD | PMID:18620774 | etoposide | increases expression | ISO | RGD:1347691 | 6480464 | Etoposide results in increased expression of FASN mRNA | CTD | PMID:17089011 | eugenol | decreases expression | ISO | | 6480464 | Eugenol results in decreased expression of FASN mRNA | CTD | PMID:21870829 | fenofibrate | increases expression | ISO | | 6480464 | Fenofibrate results in increased expression of FASN mRNA | CTD | PMID:17118139 | ferulic acid | decreases expression | ISO | | 6480464 | ferulic acid results in decreased expression of FASN mRNA | CTD | PMID:21870829 | folic acid | multiple interactions | ISO | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FASN gene | CTD | PMID:20938992 | fructose | increases expression | ISO | | 6480464 | Fructose results in increased expression of FASN mRNA | CTD | PMID:15066988 | fructose | increases expression | ISO | | 6480464 | Fructose results in increased expression of FASN mRNA | CTD | PMID:15066988 PMID:22698815 | fructose | multiple interactions | ISO | | 6480464 | Phenylbutyrates inhibits the reaction [Fructose results in increased expression of FASN mRNA] | CTD | PMID:22698815 | fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of FASN mRNA | CTD | PMID:12065722 more ... | fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of FASN mRNA | CTD | PMID:18346472 more ... | fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of FASN protein | CTD | PMID:21781943 | fructose | multiple interactions | EXP | | 6480464 | [Copper deficiency co-treated with Fructose] results in increased expression of FASN protein | CTD | PMID:21781943 | fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of FASN mRNA | CTD | PMID:9566986 more ... | fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of FASN mRNA | CTD | PMID:19196556 more ... | fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of FASN mRNA | CTD | PMID:18346472 more ... | fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of FASN mRNA | CTD | PMID:9566986 more ... | fructose | increases activity | EXP | | 6480464 | Fructose results in increased activity of FASN protein | CTD | PMID:8759368 PMID:9566986 | fructose | multiple interactions | EXP | | 6480464 | Tea inhibits the reaction [Fructose results in increased expression of FASN mRNA] | CTD | PMID:19193814 | fructose | increases activity | EXP | | 6480464 | Fructose results in increased activity of FASN protein | CTD | PMID:9566986 PMID:8759368 | fructose | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Fructose results in increased expression of FASN mRNA] | CTD | PMID:19196556 | fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of FASN mRNA | CTD | PMID:8759368 more ... | fructose | multiple interactions | ISO | | 6480464 | Triolein inhibits the reaction [SCD1 gene mutant form inhibits the reaction [Fructose results in increased expression of FASN mRNA]]; more ... | CTD | PMID:15066988 | fulvestrant | multiple interactions | ISO | RGD:1347691 | 6480464 | fulvestrant inhibits the reaction [Norethynodrel results in increased activity of FASN protein] | CTD | PMID:15870863 | gamma-hexachlorocyclohexane | affects activity | EXP | | 6480464 | Lindane affects the activity of FASN protein | CTD | PMID:7535533 | glucose | increases expression | ISO | | 6480464 | Glucose results in increased expression of FASN mRNA | CTD | PMID:15066988 | glucose | multiple interactions | ISO | RGD:1347691 | 6480464 | [Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides; more ... | CTD | PMID:18482975 | glucose | increases expression | ISO | RGD:1347691 | 6480464 | Glucose results in increased expression of FASN protein | CTD | PMID:18482975 | glutathione | decreases expression | EXP | | 6480464 | Glutathione deficiency results in decreased expression of FASN mRNA | CTD | PMID:20621112 | haloperidol | increases expression | ISO | RGD:1347691 | 6480464 | Haloperidol results in increased expression of FASN mRNA | CTD | PMID:16027736 | ibuprofen | affects expression | ISO | RGD:1347691 | 6480464 | Ibuprofen affects the expression of FASN protein | CTD | PMID:18351690 | ibuprofen | decreases expression | ISO | RGD:1347691 | 6480464 | Ibuprofen results in decreased expression of FASN mRNA | CTD | PMID:18351690 | indinavir | increases expression | ISO | | 6480464 | Indinavir results in increased expression of FASN mRNA | CTD | PMID:11741158 | indinavir | multiple interactions | ISO | | 6480464 | [Stavudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA; more ... | CTD | PMID:11741158 | isotretinoin | decreases expression | ISO | RGD:1347691 | 6480464 | Isotretinoin results in decreased expression of FASN mRNA | CTD | PMID:15982314 PMID:20436886 | isotretinoin | decreases expression | ISO | RGD:1347691 | 6480464 | Isotretinoin results in decreased expression of FASN mRNA | CTD | PMID:20436886 PMID:15982314 | L-methionine | multiple interactions | ISO | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FASN gene | CTD | PMID:20938992 | L-methionine | multiple interactions | ISO | | 6480464 | [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of FASN mRNA | CTD | PMID:23038002 | lamivudine | multiple interactions | ISO | | 6480464 | [Stavudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA; more ... | CTD | PMID:11741158 | lead(0) | increases expression | ISO | RGD:1347691 | 6480464 | Lead results in increased expression of FASN mRNA | CTD | PMID:19921347 | lithocholic acid | decreases expression | ISO | | 6480464 | Lithocholic Acid results in decreased expression of FASN mRNA | CTD | PMID:20359477 | lithocholic acid | multiple interactions | ISO | | 6480464 | Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in decreased expression of FASN mRNA] | CTD | PMID:20359477 | losartan | multiple interactions | EXP | | 6480464 | Losartan inhibits the reaction [AGT protein results in increased expression of FASN mRNA] | CTD | PMID:19109942 | lovastatin | increases expression | ISO | RGD:1347691 | 6480464 | Lovastatin results in increased expression of FASN mRNA | CTD | PMID:11728391 | melatonin | multiple interactions | ISO | | 6480464 | Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of FASN mRNA] | CTD | PMID:21689150 | metformin | decreases expression | ISO | RGD:1347691 | 6480464 | Metformin results in decreased expression of FASN mRNA | CTD | PMID:20956498 | metformin | decreases expression | ISO | | 6480464 | Metformin results in decreased expression of FASN mRNA | CTD | PMID:21870829 | metformin | multiple interactions | ISO | | 6480464 | [Metformin results in increased activity of PRKAA2 protein] which results in decreased activity of FASN protein | CTD | PMID:17635921 | mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [atorvastatin results in increased expression of FASN mRNA] | CTD | PMID:12056585 | mifepristone | multiple interactions | ISO | RGD:1347691 | 6480464 | Mifepristone inhibits the reaction [Norethynodrel results in increased activity of FASN protein] | CTD | PMID:15870863 | mitoxantrone | decreases response to substance | ISO | RGD:1347691 | 6480464 | FASN protein results in decreased susceptibility to Mitoxantrone | CTD | PMID:18281512 | mitoxantrone | multiple interactions | ISO | RGD:1347691 | 6480464 | orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Mitoxantrone] | CTD | PMID:18281512 | mono(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1347691 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of FASN mRNA | CTD | PMID:23118965 | N-methyl-4-phenylpyridinium | decreases expression | ISO | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of FASN mRNA | CTD | PMID:22776087 | N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | ISO | RGD:1347691 | 6480464 | Methylnitronitrosoguanidine results in increased expression of FASN mRNA | CTD | PMID:12634122 | N-methyl-N-nitrosurea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of FASN mRNA | CTD | PMID:16525678 | naloxone | decreases expression | EXP | | 6480464 | Naloxone results in decreased expression of FASN mRNA | CTD | PMID:17522070 | nickel atom | decreases expression | ISO | | 6480464 | Nickel results in decreased expression of FASN mRNA | CTD | PMID:12540486 | nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of FASN mRNA | CTD | PMID:22110744 | nickel dichloride | decreases expression | ISO | RGD:1347691 | 6480464 | nickel chloride results in decreased expression of FASN mRNA | CTD | PMID:17312168 | nickel sulfate | increases expression | ISO | RGD:1347691 | 6480464 | nickel sulfate results in increased expression of FASN mRNA | CTD | PMID:16780908 | nickel sulfate | decreases expression | ISO | | 6480464 | nickel sulfate results in decreased expression of FASN mRNA | CTD | PMID:16100012 | nicotinic acid | decreases expression | ISO | RGD:1347691 | 6480464 | Niacin results in decreased expression of FASN mRNA | CTD | PMID:19131065 | norethisterone | increases activity | ISO | RGD:1347691 | 6480464 | Norethindrone results in increased activity of FASN protein | CTD | PMID:15870863 | olanzapine | increases expression | ISO | | 6480464 | olanzapine results in increased expression of FASN mRNA | CTD | PMID:17651982 | olmesartan | decreases expression | EXP | | 6480464 | olmesartan medoxomil results in decreased expression of FASN mRNA | CTD | PMID:18501344 | ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of FASN mRNA | CTD | PMID:16716893 | palmitic acid | multiple interactions | ISO | | 6480464 | orlistat inhibits the reaction [FASN protein results in increased chemical synthesis of Palmitic Acid] | CTD | PMID:21213365 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of FASN mRNA | CTD | PMID:17522070 PMID:15084756 | paracetamol | increases expression | ISO | RGD:1347691 | 6480464 | Acetaminophen results in increased expression of FASN mRNA | CTD | PMID:21420995 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of FASN mRNA | CTD | PMID:15084756 PMID:17522070 | paracetamol | affects expression | ISO | | 6480464 | Acetaminophen affects the expression of FASN mRNA | CTD | PMID:17562736 | perfluorobutyric acid | increases expression | EXP | | 6480464 | perfluorobutyric acid analog results in increased expression of FASN mRNA | CTD | PMID:21878386 | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of FASN mRNA | CTD | PMID:19162173 | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of FASN mRNA | CTD | PMID:21723365 PMID:19162173 | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of FASN mRNA | CTD | PMID:19162173 PMID:21723365 | perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of FASN mRNA | CTD | PMID:18692542 | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of FASN mRNA | CTD | PMID:19162173 | peroxynitrous acid | multiple interactions | ISO | | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [Peroxynitrous Acid results in decreased activity of FASN protein]; more ... | CTD | PMID:17635921 | peroxynitrous acid | decreases activity | ISO | | 6480464 | Peroxynitrous Acid results in decreased activity of FASN protein | CTD | PMID:17635921 | phenobarbital | affects expression | ISO | | 6480464 | Phenobarbital affects the expression of FASN mRNA | CTD | PMID:23091169 | phosphocholine | multiple interactions | ISO | RGD:1347691 | 6480464 | [Cerulenin results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine; more ... | CTD | PMID:18723500 | phosphorylcholine chloride | multiple interactions | ISO | RGD:1347691 | 6480464 | [Cerulenin results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine; more ... | CTD | PMID:18723500 | pirinixic acid | multiple interactions | ISO | | 6480464 | Ethanol inhibits the reaction [pirinixic acid results in decreased expression of FASN mRNA] | CTD | PMID:18620774 | pirinixic acid | increases expression | ISO | | 6480464 | pirinixic acid results in increased expression of FASN mRNA | CTD | PMID:15302862 more ... | pirinixic acid | increases expression | ISO | | 6480464 | pirinixic acid results in increased expression of FASN mRNA | CTD | PMID:18301758 more ... | pirinixic acid | increases expression | ISO | | 6480464 | pirinixic acid results in increased expression of FASN mRNA | CTD | PMID:17118139 more ... | pirinixic acid | increases expression | ISO | | 6480464 | pirinixic acid results in increased expression of FASN mRNA | CTD | PMID:15375163 more ... | pirinixic acid | increases expression | ISO | | 6480464 | pirinixic acid results in increased expression of FASN mRNA | CTD | PMID:15302862 more ... | pirinixic acid | increases expression | ISO | | 6480464 | pirinixic acid results in increased expression of FASN mRNA | CTD | PMID:20059764 more ... | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of FASN mRNA | CTD | PMID:19162173 | pirinixic acid | multiple interactions | EXP | | 6480464 | [[[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased localization of and results in decreased activity of SREBF1 protein] which results in decreased expression of FASN mRNA] which results in decreased abundance of Triglycerides | CTD | PMID:19248225 | pirinixic acid | multiple interactions | ISO | | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of FASN mRNA] | CTD | PMID:20059764 | pirinixic acid | multiple interactions | ISO | | 6480464 | PPARA protein affects the reaction [pirinixic acid results in increased expression of FASN mRNA] | CTD | PMID:15777286 | pirinixic acid | increases expression | ISO | | 6480464 | pirinixic acid results in increased expression of FASN mRNA | CTD | PMID:15375163 more ... | pirinixic acid | decreases expression | ISO | | 6480464 | pirinixic acid results in decreased expression of FASN mRNA | CTD | PMID:18620774 | pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of FASN mRNA | CTD | PMID:19162173 | pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | | 6480464 | Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in decreased expression of FASN mRNA] | CTD | PMID:20359477 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | | 6480464 | Pregnenolone Carbonitrile results in increased expression of FASN mRNA | CTD | PMID:20359477 | propylparaben | increases expression | ISO | | 6480464 | propylparaben results in increased expression of FASN mRNA | CTD | PMID:22956630 | prostaglandin E2 | multiple interactions | ISO | | 6480464 | Dinoprostone promotes the reaction [celecoxib results in decreased activity of FASN protein] | CTD | PMID:19159447 | quercetin | decreases expression | ISO | RGD:1347691 | 6480464 | Quercetin results in decreased expression of FASN mRNA | CTD | PMID:19729006 | quercetin | decreases expression | ISO | | 6480464 | Quercetin results in decreased expression of FASN mRNA | CTD | PMID:17032037 | quercetin | decreases activity | ISO | | 6480464 | Quercetin results in decreased activity of FASN protein | CTD | PMID:17032037 | resveratrol | decreases expression | ISO | | 6480464 | [resveratrol results in decreased expression of SREBF1 mRNA] which results in decreased expression of FASN mRNA | CTD | PMID:22659145 | resveratrol | decreases expression | ISO | | 6480464 | resveratrol results in decreased expression of FASN mRNA | CTD | PMID:18755807 | resveratrol | decreases expression | ISO | RGD:1347691 | 6480464 | resveratrol results in decreased expression of FASN mRNA | CTD | PMID:20878097 | resveratrol | multiple interactions | ISO | | 6480464 | resveratrol inhibits the reaction [Ethanol results in increased expression of FASN mRNA] | CTD | PMID:18755807 | resveratrol | decreases expression | ISO | | 6480464 | resveratrol results in decreased expression of FASN mRNA | CTD | PMID:18755807 PMID:18930334 | resveratrol | multiple interactions | ISO | RGD:1347691 | 6480464 | [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides] | CTD | PMID:18482975 | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of FASN mRNA | CTD | PMID:16626303 | resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [INS1 protein results in increased expression of FASN mRNA] | CTD | PMID:16626303 | rosiglitazone | increases expression | ISO | RGD:1347691 | 6480464 | rosiglitazone results in increased expression of FASN mRNA | CTD | PMID:16806087 | rosiglitazone | increases expression | ISO | | 6480464 | rosiglitazone results in increased expression of FASN mRNA | CTD | PMID:23322813 | rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of FASN mRNA | CTD | PMID:21515302 | rosiglitazone | increases expression | ISO | RGD:1347691 | 6480464 | rosiglitazone results in increased expression of FASN mRNA | CTD | PMID:17148569 PMID:16806087 | rosiglitazone | affects expression | ISO | | 6480464 | rosiglitazone affects the expression of FASN mRNA | CTD | PMID:22013433 | rosiglitazone | increases expression | ISO | RGD:1347691 | 6480464 | rosiglitazone results in increased expression of FASN mRNA | CTD | PMID:16806087 PMID:17148569 | rosiglitazone | decreases expression | ISO | | 6480464 | rosiglitazone results in decreased expression of FASN mRNA | CTD | PMID:17245590 | rosiglitazone | multiple interactions | ISO | | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of FASN mRNA] | CTD | PMID:22173916 | rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Fructose results in increased expression of FASN mRNA] | CTD | PMID:19196556 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of FASN mRNA | CTD | PMID:19013527 PMID:19693701 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of FASN mRNA | CTD | PMID:19693701 PMID:19013527 | selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of FASN mRNA | CTD | PMID:19022953 | selenium atom | increases expression | ISO | RGD:1347691 | 6480464 | Selenium results in increased expression of FASN mRNA | CTD | PMID:19244175 | sildenafil | increases expression | ISO | | 6480464 | sildenafil results in increased expression of FASN mRNA | CTD | PMID:20471953 | silicon dioxide | increases activity | EXP | | 6480464 | Silicon Dioxide results in increased activity of FASN protein | CTD | PMID:1647683 | simvastatin | increases expression | ISO | RGD:1347691 | 6480464 | Simvastatin results in increased expression of FASN mRNA | CTD | PMID:11728391 | simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of FASN mRNA | CTD | PMID:12056585 | stavudine | multiple interactions | ISO | | 6480464 | [Stavudine co-treated with Lamivudine] results in increased expression of FASN mRNA; more ... | CTD | PMID:11741158 | stavudine | decreases expression | ISO | | 6480464 | Stavudine results in decreased expression of FASN protein | CTD | PMID:15722030 | streptozocin | multiple interactions | EXP | | 6480464 | GHRL protein promotes the reaction [Streptozocin results in decreased expression of FASN mRNA]; more ... | CTD | PMID:20219977 | streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of FASN mRNA | CTD | PMID:20219977 | tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of FASN mRNA | CTD | PMID:19224547 | tamoxifen | increases expression | ISO | | 6480464 | Tamoxifen results in increased expression of FASN mRNA | CTD | PMID:23038002 | tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of FASN mRNA | CTD | PMID:17630414 | tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of FASN mRNA | CTD | PMID:17630414 PMID:19224547 | tamoxifen | multiple interactions | EXP | | 6480464 | [Tamoxifen co-treated with bexarotene] results in increased expression of FASN mRNA | CTD | PMID:17630414 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of FASN mRNA | CTD | PMID:16239168 more ... | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of FASN mRNA | CTD | PMID:17522070 more ... | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of FASN mRNA | CTD | PMID:16239168 more ... | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of FASN mRNA | CTD | PMID:19224547 more ... | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of FASN mRNA | CTD | PMID:19224547 more ... | tetracycline | decreases expression | EXP | | 6480464 | Tetracycline results in decreased expression of FASN mRNA | CTD | PMID:19224547 PMID:17522070 | tetracycline | decreases expression | EXP | | 6480464 | Tetracycline results in decreased expression of FASN mRNA | CTD | PMID:17522070 PMID:19224547 | trans-4-coumaric acid | decreases expression | ISO | | 6480464 | 4-coumaric acid results in decreased expression of FASN mRNA | CTD | PMID:21870829 | trans-resveratrol | decreases expression | ISO | | 6480464 | [resveratrol results in decreased expression of SREBF1 mRNA] which results in decreased expression of FASN mRNA | CTD | PMID:22659145 | trans-resveratrol | decreases expression | ISO | | 6480464 | resveratrol results in decreased expression of FASN mRNA | CTD | PMID:18755807 | trans-resveratrol | decreases expression | ISO | RGD:1347691 | 6480464 | resveratrol results in decreased expression of FASN mRNA | CTD | PMID:20878097 | trans-resveratrol | multiple interactions | ISO | | 6480464 | resveratrol inhibits the reaction [Ethanol results in increased expression of FASN mRNA] | CTD | PMID:18755807 | trans-resveratrol | decreases expression | ISO | | 6480464 | resveratrol results in decreased expression of FASN mRNA | CTD | PMID:18755807 PMID:18930334 | trans-resveratrol | multiple interactions | ISO | RGD:1347691 | 6480464 | [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides] | CTD | PMID:18482975 | trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [INS1 protein results in increased expression of FASN mRNA] | CTD | PMID:16626303 | trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of FASN mRNA | CTD | PMID:16626303 | tributylstannane | increases expression | ISO | | 6480464 | tributyltin results in increased expression of FASN mRNA | CTD | PMID:23322813 | trichloroethene | increases expression | ISO | | 6480464 | Trichloroethylene results in increased expression of FASN mRNA | CTD | PMID:19448997 | trichloroethene | increases expression | ISO | | 6480464 | Trichloroethylene results in increased expression of FASN mRNA | CTD | PMID:19254012 PMID:19448997 | triclosan | decreases activity | ISO | | 6480464 | Triclosan results in decreased activity of FASN protein | CTD | PMID:15707987 | triclosan | decreases activity | EXP | | 6480464 | Triclosan results in decreased activity of FASN protein | CTD | PMID:15358634 | triclosan | decreases expression | ISO | | 6480464 | Triclosan results in decreased expression of FASN mRNA | CTD | PMID:15707987 | triolein | multiple interactions | ISO | | 6480464 | Triolein inhibits the reaction [SCD1 gene mutant form inhibits the reaction [Fructose results in increased expression of FASN mRNA]]; more ... | CTD | PMID:15066988 | troglitazone | increases expression | ISO | RGD:1347691 | 6480464 | troglitazone results in increased expression of FASN mRNA | CTD | PMID:19022234 | troglitazone | multiple interactions | EXP | | 6480464 | [[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein] which results in decreased expression of FASN mRNA] which results in decreased abundance of Triglycerides | CTD | PMID:19248225 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of FASN mRNA | CTD | PMID:19022234 | tunicamycin | increases expression | ISO | RGD:1347691 | 6480464 | Tunicamycin results in increased expression of FASN mRNA | CTD | PMID:22414386 | urethane | increases expression | ISO | | 6480464 | Urethane results in increased expression of FASN protein | CTD | PMID:18413838 | ursodeoxycholic acid | decreases expression | EXP | | 6480464 | Ursodeoxycholic Acid results in decreased expression of FASN mRNA | CTD | PMID:15885361 | valproic acid | affects expression | ISO | | 6480464 | Valproic Acid affects the expression of FASN mRNA | CTD | PMID:17292431 | valproic acid | increases expression | ISO | | 6480464 | Valproic Acid results in increased expression of FASN mRNA | CTD | PMID:15345369 PMID:21427059 | valproic acid | decreases expression | ISO | | 6480464 | Valproic Acid results in decreased expression of FASN mRNA | CTD | PMID:21427059 PMID:19136453 | valproic acid | decreases expression | ISO | | 6480464 | Valproic Acid results in decreased expression of FASN mRNA | CTD | PMID:19136453 PMID:21427059 | valproic acid | decreases expression | ISO | | 6480464 | Valproic Acid results in decreased expression of FASN mRNA | CTD | PMID:21427059 | valproic acid | increases expression | ISO | | 6480464 | Valproic Acid results in increased expression of FASN mRNA | CTD | PMID:21427059 PMID:15345369 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of FASN mRNA | CTD | PMID:19224547 | zidovudine | affects expression | ISO | RGD:1347691 | 6480464 | Zidovudine affects the expression of FASN mRNA | CTD | PMID:20032539 | zidovudine | decreases expression | ISO | | 6480464 | Zidovudine results in decreased expression of FASN protein | CTD | PMID:15722030 | zidovudine | multiple interactions | ISO | | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA; more ... | CTD | PMID:11741158 | zinc atom | affects activity | EXP | | 6480464 | Zinc affects the activity of FASN protein | CTD | PMID:17181878 | zinc dichloride | decreases expression | ISO | RGD:1347691 | 6480464 | zinc chloride results in decreased expression of FASN mRNA | CTD | PMID:21540303 | zinc(0) | affects activity | EXP | | 6480464 | Zinc affects the activity of FASN protein | CTD | PMID:17181878 | |
Gene Ontology AnnotationsBiological Process











